Cargando…

Boosting in the age of Omicron

A third dose of the inactivated vaccine CoronaVac fails to stimulate the production of neutralizing antibodies which target the Omicron variant.

Detalles Bibliográficos
Autor principal: Sigal, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110234/
https://www.ncbi.nlm.nih.gov/pubmed/37066867
http://dx.doi.org/10.7554/eLife.87358
_version_ 1785027227849588736
author Sigal, Alex
author_facet Sigal, Alex
author_sort Sigal, Alex
collection PubMed
description A third dose of the inactivated vaccine CoronaVac fails to stimulate the production of neutralizing antibodies which target the Omicron variant.
format Online
Article
Text
id pubmed-10110234
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-101102342023-04-18 Boosting in the age of Omicron Sigal, Alex eLife Epidemiology and Global Health A third dose of the inactivated vaccine CoronaVac fails to stimulate the production of neutralizing antibodies which target the Omicron variant. eLife Sciences Publications, Ltd 2023-04-17 /pmc/articles/PMC10110234/ /pubmed/37066867 http://dx.doi.org/10.7554/eLife.87358 Text en © 2023, Sigal https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Epidemiology and Global Health
Sigal, Alex
Boosting in the age of Omicron
title Boosting in the age of Omicron
title_full Boosting in the age of Omicron
title_fullStr Boosting in the age of Omicron
title_full_unstemmed Boosting in the age of Omicron
title_short Boosting in the age of Omicron
title_sort boosting in the age of omicron
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110234/
https://www.ncbi.nlm.nih.gov/pubmed/37066867
http://dx.doi.org/10.7554/eLife.87358
work_keys_str_mv AT sigalalex boostingintheageofomicron